LGRNX
Price
$25.83
Change
+$0.33 (+1.29%)
Updated
Apr 11 closing price
Net Assets
13.39B
RGEBX
Price
$64.37
Change
+$1.01 (+1.59%)
Updated
Apr 11 closing price
Net Assets
260.89B
Ad is loading...

LGRNX vs RGEBX

Header iconLGRNX vs RGEBX Comparison
Open Charts LGRNX vs RGEBXBanner chart's image
Loomis Sayles Growth N
Price$25.83
Change+$0.33 (+1.29%)
VolumeN/A
Net Assets13.39B
American Funds Growth Fund of Amer R2E
Price$64.37
Change+$1.01 (+1.59%)
VolumeN/A
Net Assets260.89B
LGRNX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGRNX vs. RGEBX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRNX is a Buy and RGEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 261B vs. LGRNX (13.4B). LGRNX (0.00) and RGEBX (0.00) have matching dividends . LGRNX was incepted earlier than RGEBX: LGRNX (12 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than LGRNX (0.57). RGEBX has a lower initial minimum investment than LGRNX: RGEBX (250) vs LGRNX (1000000). LGRNX annual gain was more profitable for investors over the last year : -2.04 vs. RGEBX (-5.95). LGRNX return over 5 years is better than : 48.86 vs. RGEBX (43.55).
LGRNXRGEBXLGRNX / RGEBX
Total Expense Ratio0.571.0952%
Annual Report Gross Expense Ratio0.571.0952%
Fund Existence12 years11 years-
Gain YTD-14.026-9.896142%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.4B261B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.04-5.9534%
Returns for 3 years11.795.16229%
Returns for 5 years48.8643.55112%
Returns for 10 years136.3344.23308%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XIFR8.750.51
+6.19%
XPLR Infrastructure LP
XP13.460.54
+4.18%
XP
SGMA1.070.01
+0.94%
SigmaTron International
FENC5.01N/A
N/A
Fennec Pharmaceuticals
OTLY8.95-0.35
-3.76%
Oatly Group AB